MP79-12 NOVEL PROLONGED ACTION FORMULATION ACETAMINOPHEN-IBUPROFEN COMBINATION THERAPY FOR TREATMENT OF NOCTURIA - A MULTI-CENTER, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, 4-ARM PHASE 2 TRIAL